*ST苏吴: 江苏吴中医药发展股份有限公司第十一届董事会第五次会议决议公告

Core Points - The board of directors of Jiangsu Wuzhong Pharmaceutical Development Co., Ltd. held its fifth meeting of the eleventh session on August 19, 2025, where all seven directors attended and approved several key resolutions [1][2] - The meeting approved the general manager's work report for the first half of 2025, with a unanimous vote of 7 in favor [1] - The board also approved the half-year report and summary for 2025, which had been reviewed and unanimously passed by the audit committee [2] - A special report on the storage and actual use of funds raised from a non-public offering in the first half of 2025 was also approved, with a unanimous vote [2] - The board approved a proposal regarding the postponement of certain fundraising investment projects, which will be disclosed in detail on August 29, 2025 [2]